De demostró que la capacidad de respuesta global a las vacunas COVID-19 de estos pacientes disminuye cuando presentan cirrosis. La cirrosis, junto con la edad y el tipo de vacuna, se asocia a respues...
Read moreSeis científicos del CSIC abordarán el reto de la energía verde y algunas de sus claves, como son la producción de hidrógeno renovable, los biocombustibles o la descarbonización.
Read moreA collaboration has been signed between the Bellvitge Biomedical Research Institute (IDIBELL), the Institute of Cancer Research (ICR) in London, and Vivan Therapeutics to jointly develop molecules tha...
Read moreIt has been revealed that LRP1-based immunotherapy reduces cardiac extracellular matrix (ECM) remodeling induced by intracellular accumulation of esterified cholesterol in cardiomyocytes.
Read moreAlthough the vector that transmits the parasite (the kissing bug) is endemic in 21 Latin American countries, the parasite has spread globally due to migratory flows.
Read moreIt has been reconfirmed that the childhood obesity pandemic affects to a greater extent those children and adolescents who live in a situation of socioeconomic vulnerability. Specifically, 6.7% more c...
Read moreIt has been has shown that the role of oxidative stress in the progression of Alzheimer's disease affects only at the cellular level and instead, damage in extracellular fluids, such as plasma and cer...
Read moreStudents and health professionals from the University of Navarra return from the Congo after researching and implementing a screening against this disease.
Read moreResearchers from the UAB and the ICN2 have developed a methodology that makes it possible for the first time to observe under the microscope, in real time, what happens when glass is heated and change...
Read moreA research team from IRB Barcelona and the biotech Nostrum Biodiscovery has developed a new type of inhibitor that blocks only some of the functions of the p38 protein. The alternative pathway that th...
Read moreSparingVision, a clinical-stage genomic medicine company developing vision-saving treatments for eye diseases, today announced that it has sold its ex vivo GIRK technology to Tenpoint Therapeutics.
Read moreInvestigadores del Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico de València, y del Instituto de Biomedicina de Sevilla (IBiS) utilizarán modelos de cultivo 3D para comprobar ...
Read more